Efficacy and safety of insulin glulisine (GLU) vs insulin lispro (LIS) as part of a basal-bolus insulin (INS) regimen in children and adolescents with type 1 diabetes (T1DM)

被引：0

作者：

Philotheou, Areti

Arslanian, Silva

Blatniczky, Laszlo

Peterkova, Valentina

Souhami, Elisabeth

Danne, Thomas

机构：

来源：

DIABETES | 2008年 / 57卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：A496 / A497

页数：2

共 50 条

[1] Efficacy and safety of insulin glulisine (GLU) versus insulin lispro (LIS) as part of a basal-bolus insulin regimen in children and adolescents with Type 1 diabetes (T1DM)
Philotheou, A.
Arslanian, S.
Blatniczky, L.
Peterkova, V.
Souhami, E.
Danne, T.
[J]. DIABETIC MEDICINE, 2008, 25
[2] Efficacy and safety of insulin glulisine versus insulin lispro as part of a basal-bolus insulin regimen in children and adolescents with type I diabetes mellitus
Philotheou, A.
Arslanian, S.
Blatniczky, L.
Peterkova, V.
Souhami, E.
Danne, T.
[J]. DIABETOLOGIA, 2008, 51 : S382 - S382
[3] Comparable Efficacy and Safety of Insulin Glulisine and Insulin Lispro When Given as Part of a Basal-Bolus Insulin Regimen in a 26-Week Trial in Pediatric Patients with Type 1 Diabetes
Philotheou, Areti
Arslanian, Silva
Blatniczky, Laszlo
Peterkova, Valentina
Souhami, Elisabeth
Danne, Thomas
[J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (03) : 327 - 334
[4] Comparison of Human Hyaluronidase plus Recombinant Human Insulin (RHI) vs. Insulin Lispro in a Basal-Bolus Regimen in Patients with Type 1 Diabetes (T1DM)
Buse, John B.
Garg, Satish K.
Skyler, Jay S.
Vaughn, Daniel E.
Muchmore, Douglas B.
[J]. DIABETES, 2011, 60 : A18 - A19
[5] Efficacy and safety of insulin glulisine(GLU) and insulin lispro (IL), combined with insulin glargine (GLAR) in patients with type 1 diabetes
Dreyer, M
Prager, R
Robinson, A
Busch, K
Souhami, E
[J]. DIABETES, 2004, 53 : A123 - A123
[6] Efficacy and safety of insulin glulisine and insulin lispro combined with insulin glargine in patients with Type 1 diabetes
Prager, R
Dreyer, M
Robinson, A
Busch, K
Penfornis, A
Souhami, E
[J]. DIABETOLOGIA, 2004, 47 : A301 - A301
[7] Dose response relation of insulin glulisine (GLU) in subjects with type 1 diabetes (T1DM)
Becker, RHA
Frick, AD
Heinemann, L
Nosek, L
Rave, K
[J]. DIABETES, 2005, 54 : A332 - A332
[8] Efficacy and Safety of a Basal-Bolus Regimen of Basal Insulin Plus Insulin Glulisine in Patients With Type 2 Diabetes: A Pooled Analysis of 5 Clinical Trials
Dailey, George
Lin, Jay
Wang, Edward
[J]. DIABETES, 2012, 61 : A284 - A284
[9] Efficacy and safety of post-meal insulin glulisine (GLU) compared with pre-meal regular human insulin (RHI) in a basal-bolus regimen with insulin glargine
Garg, S
Rosenstock, J
Ways, K
[J]. DIABETES, 2004, 53 : A125 - A125
[10] Glycaemic control with insulin glulisine versus regular human insulin in a basal-bolus regimen in patients with Type 2 diabetes
Dailey, G
Rosenstock, J
Moses, R
Ways, K
[J]. DIABETOLOGIA, 2004, 47 : A265 - A266

← 1 2 3 4 5 →